My Account

Username :

Password :


Create New Account
Forgot Password?
     

Keyword Search


     

Speakers


Browse all DCP Speakers

     

Shopping Cart

You have (0) items
in your cart.



     

Contact Us


EMAIL US

     

Return to Digital Conference Providers Inc. Events Library Menu

Steve Perfetto
[ Close ]
Steve Perfetto Biography Staff Scientist and Manager, Flow Core Facility, Vaccine Research Center, NIH, Bethesda, MD Affiliation

Website

Steve Perfetto Steve PerfettoStaff Scientist and Manager, Flow Core Facility, Vaccine Research Center, NIH, Bethesda  (more ...)


Steven Perlman, DDS, MScD
[ Close ]
Steven Perlman, DDS, MScD Biography Associate Clinical Professor, Department of Pediatric Dentistry, Boston, University, Swampscott, MA Affiliation

Boston, University

Website

Steven Perlman, DDS, MScD Steven Perlman, DDS, MScDAssociate Clinical Professor, Department of Pediatric Dentistry, Boston, University, Swampscott  (more ...)


Steve  Perrin, PhD
[ Close ]
Steve Perrin, PhD Biography Dr. Steven Perrin is currently the Chief Executive Officer and Chief Scientific Officer at the ALS Therapy Development Institute (ALS TDI) in Cambridge, MA. He earned his Ph.D. at Boston University Medical Center studying the transcriptional regulation of genes during adipocyte and myocyte differentiation. Dr. Perrin moved into the pharmaceutical industry in 1997 holding positions at the Hoechst-Ariad Genomics Center, Aventis Pharmaceuticals and more recently as Director of Molecular Profiling at Biogen Idec. Dr. Perrin joined ALS TDI in 2007 as part of historical collaboration between the Muscular Dystrophy Association, Augie’s Quest and ALS TDI to develop effective therapeutics for ALS patients. Since joining ALS TDI Steven has spearheaded the development of computational biology capabilities and information management systems to more clearly understand the molecular mechanisms associated with disease onset and progression in neurodegenerative diseases. He has expanded ALS TDI’s drug screening program to include expertise in the generation and assessment of gene therapy vectors and protein biologics in preclinical models of neurodegeneration. He has developed a business plan to facilitate pharmaceutical partnerships for rapid clinical development and commercialization of promising targets for ALS patients. Dr. Perrin is a frequent participant in international conferences in computational biology, genomics, drug development, and neurodegeneration. Affiliation

Website

Steve  Perrin, PhD Steve Perrin, PhDDr. Steven Perrin is currently the Chief Executive Officer and Chief Scientific Officer at the ALS Therapy Development Institute (ALS TDI) in Camb  (more ...)


Steve Perrin, PhD
[ Close ]
Steve Perrin, PhD Biography Dr. Steven Perrin is currently the Chief Executive Officer and Chief Scientific Officer at the ALS Therapy Development Institute (ALS TDI) in Cambridge, MA. He earned his Ph.D. at Boston University Medical Center studying the transcriptional regulation of genes during adipocyte and myocyte differentiation. Dr. Perrin moved into the pharmaceutical industry in 1997 holding positions at the Hoechst-Ariad Genomics Center, Aventis Pharmaceuticals and more recently as Director of Molecular Profiling at Biogen Idec. Dr. Perrin joined ALS TDI in 2007 as part of historical collaboration between the Muscular Dystrophy Association, Augie’s Quest and ALS TDI to develop effective therapeutics for ALS patients. Since joining ALS TDI Steven has spearheaded the development of computational biology capabilities and information management systems to more clearly understand the molecular mechanisms associated with disease onset and progression in neurodegenerative diseases. He has expanded ALS TDI’s drug screening program to include expertise in the generation and assessment of gene therapy vectors and protein biologics in preclinical models of neurodegeneration. He has developed a business plan to facilitate pharmaceutical partnerships for rapid clinical development and commercialization of promising targets for ALS patients. Dr. Perrin is a frequent participant in international conferences in computational biology, genomics, drug development, and neurodegeneration. Affiliation

ALS Therapy Development Institute

Website

Steve Perrin, PhD Steve Perrin, PhDDr. Steven Perrin is currently the Chief Executive Officer and Chief Scientific Officer at the ALS Therapy Development Institute (ALS TDI) in Camb  (more ...)


Cassandra  Perry
[ Close ]
Cassandra Perry Biography MS, University of Massachusetts Medical School Office of Foster Care and Adoption Affiliation

Website

Cassandra  Perry Cassandra PerryMS, University of Massachusetts Medical School Office of Foster Care and Adop  (more ...)


April  Perry
[ Close ]
April Perry Biography APRN, MEd, Duke Home Care & Hospice, Durham, NC Affiliation

Duke Home Care & Hospice

Website

April  Perry April PerryAPRN, MEd, Duke Home Care & Hospice, Durham,   (more ...)


Richard Perry, DDS
[ Close ]
Richard Perry, DDS Biography Private practice, Oak Park, IL Affiliation

Website

Richard Perry, DDS Richard Perry, DDSPrivate practice, Oak Park,   (more ...)


Elaine  Pesavento
[ Close ]
Elaine Pesavento Biography CPA, MST, Berwyn, IL, Managing Director and Vice-President of Pesavento & Pesavento, Ltd. Affiliation

Website

Elaine  Pesavento Elaine PesaventoCPA, MST, Berwyn, IL, Managing Director and Vice-President of Pesavento & Pesavento,   (more ...)


Suzana  Petanceska, PhD
[ Close ]
Suzana Petanceska, PhD Biography Dr. Suzana Petanceska received a B.S. degree in molecular biology and physiology from the University of Belgrade, Yugoslavia and a Ph.D. degree in Pharmacology from New York University. Following her postdoctoral training at Rockefeller University (1995-1998) and at the Nathan Kline Institute of NYU (1998-2000) she became an Assistant Professor of Psychiatry and Pharmacology at the Nathan Kline Institute of NYU (2001-2005). Her research focused on the role of disrupted sterol metabolism in the development of Alzheimer’s disease amyloidosis and the mechanisms by which estrogens and cholesterol-lowering drugs might exert neuroprotection. In 2005 she joined the Neuroscience and Neuropsychology of Aging Program at the National Institute on Aging where she serves as a Program Director covering research areas that address the role of metabolic and vascular factors in normal brain aging and in Alzheimer’s disease. She also facilitates the development of NIA’s drug discovery and preclinical drug development initiatives for AD, mild cognitive impairment and age-associated cognitive decline. Affiliation

National Institute on Aging

Website

Suzana  Petanceska, PhD Suzana Petanceska, PhDDr. Suzana Petanceska received a B.S. degree in molecular biology and physiology from the University of Belgrade, Yugoslavia and a Ph.D. degree in  (more ...)


Suzana  Petanceska, PhD
[ Close ]
Suzana Petanceska, PhD Biography Dr Suzana Petanceska received a B.S. degree in molecular biology and physiology from the University of Belgrade, Yugoslavia and a Ph.D. degree in Pharmacology from New York University. Following her postdoctoral training at Rockefeller University (1995-1998) and at the Nathan Kline Institute of NYU (1998-2000) she became an Assistant Professor of Psychiatry and Pharmacology at the Nathan Kline Institute of NYU (2001-2005). Her research focused on the role of disrupted sterol metabolism in the development of Alzheimer’s disease amyloidosis and the mechanisms by which estrogens and cholesterol-lowering drugs might exert neuroprotection. In 2005 she joined the Neuroscience and Neuropsychology of Aging Program at the National Institute on Aging where she serves as a Program Director covering research areas that address the role of metabolic and vascular factors in normal brain aging and in Alzheimer’s disease. She also facilitates the development of NIA’s drug discovery and preclinical drug development initiatives for AD, mild cognitive impairment and age-associated cognitive decline. Affiliation

Website

Suzana  Petanceska, PhD Suzana Petanceska, PhDDr Suzana Petanceska received a B.S. degree in molecular biology and physiology from the University of Belgrade, Yugoslavia and a Ph.D. degree in   (more ...)



PREV10 -  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456  -  NEXT10
All Libraries

Contact Us : customersupport@dcproviders.com
Digital Conference Providers, Inc. - 100 S. Cass Ave. Ste 200 - Westmont, IL 60559
Phone (630) 963-8311 - Fax (630) 963-8312